StockData
HYPDNasdaqFinance ServicesFiscal year ends December 31

HYPERION DEFI, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.86+0.02 (+0.70%)

Close on Oct 19, 2026

Market cap
$48.74M
P/E (TTM)
–
Dividend yield
–

About Hyperion Defi

Finance Services, SIC 6199

Hyperion DeFi, Inc. operates as a digital asset treasury company focused on accumulating and deploying Hyperliquid’s native token, HYPE, while maintaining an ophthalmic technology business. The company provides shareholders with exposure to the decentralized finance ecosystem by staking tokens, operating a joint network validator node, and providing liquidity and token inventory under service agreements to decentralized protocols. In addition, the firm develops the Optejet user-filled device, a precision ocular liquid delivery system designed to administer front-of-the-eye medications with reduced dosage volume and improved compliance compared to traditional eye drops.

The company conducts its corporate and development activities from its executive headquarters in Laguna Hills, California. It operates with a team of nine full-time employees, engaging specialized consultants and infrastructure contractors to assist in running its validator operations, managing decentralized finance interactions, and pursuing regulatory clearance and commercialization transactions for its medical delivery device.

Summary of the business section of Hyperion Defi's latest annual report, written by StockData.

Company profile

Company

Legal name
HYPERION DEFI, INC.
Founded
2014
Headquarters
Dallas, TX
Address
3090 Nowitzki Way, Suite 300 75219
Phone
(833) 393-6684
Employees
9, Dec 31, 2025
Industry
Finance Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Marcum LLP, New York, New York

Stock & identifiers

Ticker
HYPD
Exchange
Nasdaq
IPO date
Jan 25, 2018
Shares outstanding
16M, Aug 10, 2026
Public float
$50.10M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-80 reverse, Feb 3, 2025; 1-for-80 reverse, Jan 31, 2025
SEC CIK
1682639
CUSIP
30234E203
ISIN
US30234E2037
LEI
254900YW7J8L89CICF84
EIN
47-1178401

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Hyunsu JungSee Remarks, Director1,345,676
Michael M. RoweChief Executive Officer, Director7,975
David R. KnoxChief Financial Officer287,556
Robert RubensteinGeneral Counsel75,000
Bren KernChief Operating Officer50,031
Happy David WaltersDirector170,847
Ellen R. StrahlmanDirector184,947
Rachel JacobsonDirector115,218
Michael S. GeltzeilerDirector146,932
Ram PalankiDirector4,235
Charles E. Mather IvDirector9,950
Tsontcho IanchulevDirector17,780

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr Jung
$9.29M$4.59M$1.98M$89–
FY2025
Mr Rowe
$488.08K$376.06K$1.98M$89–
FY2024
Mr Rowe
$807.76K$509.68K$413.27K$4–
FY2023
Mr Rowe
$775.47K$1.18M$626.22K$52–
FY2022
Mr Ianchulev
$732.38K$731.68K$651.29K$41–
FY2022
Mr Rowe
$1.33M$1.29M$651.29K$41–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had nine employees, all of which are full-time employees.”

Corporate history

Events identified from SEC filings